Pnl30 Forecasting the Impact of Adding a New Drug on Formulary Using Medical Claims Data and Clinical Literature: A Case Study of Insomnia Treatment

Eszopiclone

“…27 Published pharmacoeconomic data on eszopiclone are limited, although the results of a study funded by the manufacturer were recently presented and discussed the impact of adding eszopiclone to an institution's formulary. Ozminkowski et al 28 used medical claims and clinical trial data from a case study of eszopiclone to develop a budget impact model that estimated the potential costs of adding a new drug to the formulary. The process involved using insomnia drug efficacy data from the published literature, a multiple regression model applied to claims data from 85,832 patients with insomnia and to clinical trial efficacy data, and estimated eszopiclone expenditures calculated by multiplying efficacy estimates by the regression-based expenditure estimates.…”